CEACAM5 and neoplasm: Tumor markers like carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are routinely utilized in the management of colorectal cancer for diagnosis, prognosis, and surveillance, but their use is limited in medullary carcinoma.